GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (TSXV:HEM) » Definitions » Net Investment Income

Hemostemix (TSXV:HEM) Net Investment Income


View and export this data going back to 2012. Start your Free Trial

What is Hemostemix Net Investment Income?

Net Investment Income only applies to insurance companies.


Hemostemix (TSXV:HEM) Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Executives
Thomas Smeenk Director